Nanoviricides, Inc. SEC filings NNVC

Nanoviricides, Inc. has 556 filings in SEC EDGAR's recent list, going back to Nov 14, 2006. Its latest annual report, Form 10-K, was filed on Sep 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on June 30.

Nanoviricides, Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Oct 21, 2026 —
DEF 14A Proxy statement Oct 8, 2026 Nov 21, 2026
8-K Current report
Officer or director change
Sep 29, 2026 Sep 28, 2026
10-K Annual report Sep 28, 2026 Jun 30, 2026
424B3 Prospectus Sep 3, 2026 —
EFFECT Filing Aug 31, 2026 —
S-3 Shelf registration Aug 21, 2026 —
8-K Current report
Material agreement, Other events
Jul 30, 2026 Jul 24, 2026
424B5 Prospectus supplement Jul 27, 2026 —
424B5 Prospectus supplement Jul 27, 2026 —
8-K Current report
Material agreement
Jul 17, 2026 Jul 17, 2026
424B5 Prospectus supplement Jul 17, 2026 —
424B3 Prospectus Jul 1, 2026 —
EFFECT Filing Jun 26, 2026 —
CORRESP Letter to the SEC Jun 23, 2026 —
DEL AM Filing Jun 22, 2026 —
UPLOAD Letter from the SEC Jun 18, 2026 —
DEL AM Filing Jun 17, 2026 —
EFFECT Filing Jun 15, 2026 —
S-3 Shelf registration Jun 15, 2026 —
CORRESP Letter to the SEC Jun 11, 2026 —
UPLOAD Letter from the SEC Jun 10, 2026 —
S-3 Shelf registration Jun 5, 2026 —
8-K Current report
Regulation FD disclosure
May 21, 2026 May 20, 2026
8-K Current report
Material agreement, Other events
May 20, 2026 May 15, 2026
424B5 Prospectus supplement May 18, 2026 —
10-Q Quarterly report May 15, 2026 Mar 31, 2026
D Filing Feb 25, 2026 —
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
424B3 Prospectus Dec 30, 2025 —
EFFECT Filing Dec 19, 2025 —
CORRESP Letter to the SEC Dec 18, 2025 —
DEL AM Filing Dec 16, 2025 —
S-3 Shelf registration Dec 15, 2025 —
8-K Current report
Shareholder vote results
Nov 26, 2025 Nov 22, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Nov 14, 2025 Nov 10, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
424B5 Prospectus supplement Nov 12, 2025 —
424B5 Prospectus supplement Nov 12, 2025 —
DEF 14A Proxy statement Oct 8, 2025 Nov 8, 2025
8-K Current report
Officer or director change
Oct 1, 2025 Sep 25, 2025
10-K Annual report Sep 29, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
8-K Current report
Shareholder vote results
Dec 12, 2024 Dec 7, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
DEF 14A Proxy statement Oct 15, 2024 Dec 7, 2024
10-K Annual report Sep 27, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Aug 9, 2024 Aug 5, 2024
424B5 Prospectus supplement Aug 9, 2024 —
10-Q Quarterly report May 15, 2024 Mar 31, 2024
UPLOAD Letter from the SEC May 13, 2024 —
CORRESP Letter to the SEC May 8, 2024 —
UPLOAD Letter from the SEC Apr 22, 2024 —
CORRESP Letter to the SEC Apr 9, 2024 —
8-K Current report
Material agreement
Apr 5, 2024 Apr 5, 2024
424B5 Prospectus supplement Apr 5, 2024 —
8-K Current report
Material agreement
Feb 16, 2024 Feb 12, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
UPLOAD Letter from the SEC Feb 13, 2024 —
8-K Current report
Shareholder vote results
Jan 19, 2024 Jan 13, 2024
DEF 14A Proxy statement Dec 4, 2023 Jan 13, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Other events
Nov 7, 2023 Nov 6, 2023
10-K Annual report Oct 13, 2023 Jun 30, 2023
NT 10-K Filing Sep 28, 2023 Jun 30, 2023
8-K Current report
Material agreement, New debt
Sep 1, 2023 Aug 29, 2023
424B5 Prospectus supplement Aug 7, 2023 —
8-K Current report
Other events
May 25, 2023 May 25, 2023
EFFECT Filing May 22, 2023 —
CORRESP Letter to the SEC May 17, 2023 —
10-Q Quarterly report May 15, 2023 Mar 31, 2023
UPLOAD Letter from the SEC May 12, 2023 —
S-3/A Form s-3/a May 8, 2023 —
S-3 Shelf registration May 5, 2023 —
8-K Current report
Material agreement
Mar 31, 2023 Mar 27, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
8-K Current report
Shareholder vote results
Feb 13, 2023 Feb 7, 2023
DEFA14A Additional proxy material Dec 23, 2022 —
8-K Current report
Shareholder vote results, Other events
Dec 22, 2022 Dec 17, 2022
DEF 14A Proxy statement Nov 15, 2022 Dec 17, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
PRE 14A Preliminary proxy statement Nov 4, 2022 Nov 4, 2022
10-K Annual report Oct 13, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Oct 11, 2022 Oct 6, 2022
NT 10-K Filing Sep 29, 2022 Jun 30, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
8-K Current report
Shareholder vote results
Nov 26, 2021 Nov 20, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-K Annual report Oct 12, 2021 Jun 30, 2021
DEF 14A Proxy statement Oct 12, 2021 Nov 20, 2021
NT 10-K Filing Sep 28, 2021 Jun 30, 2021
8-K Current report
Regulation FD disclosure, Other events
Sep 21, 2021 Sep 21, 2021
8-K Current report
Material agreement, Officer or director change
Sep 15, 2021 Sep 9, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
8-K Current report
Shareholder vote results
Dec 10, 2020 Dec 5, 2020
424B5 Prospectus supplement Dec 3, 2020 —
8-K Current report
Officer or director change
Nov 19, 2020 Nov 13, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
DEF 14A Proxy statement Oct 26, 2020 Dec 5, 2020
10-K Annual report Oct 13, 2020 Jun 30, 2020
NT 10-K Filing Sep 28, 2020 Jun 30, 2020
8-K Current report
Regulation FD disclosure
Sep 4, 2020 Sep 3, 2020
8-K Current report
Material agreement
Aug 3, 2020 Jul 31, 2020
424B5 Prospectus supplement Jul 31, 2020 —
8-K Current report
Material agreement, Other events
Jul 13, 2020 Jul 8, 2020
424B5 Prospectus supplement Jul 9, 2020 —
424B5 Prospectus supplement Jul 9, 2020 —
10-Q Quarterly report Jun 22, 2020 Mar 31, 2020
8-K Current report
Officer or director change
Jun 4, 2020 May 29, 2020
8-K Current report
Material agreement, Other events
May 22, 2020 May 21, 2020
424B5 Prospectus supplement May 22, 2020 —
8-K Current report
Officer or director change
May 19, 2020 May 15, 2020
8-K Current report
Other events
May 14, 2020 May 14, 2020
EFFECT Filing Apr 2, 2020 —
CORRESP Letter to the SEC Mar 31, 2020 —
UPLOAD Letter from the SEC Mar 26, 2020 —
S-3 Shelf registration Mar 24, 2020 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Mar 20, 2020 Mar 16, 2020
DEF 14A Proxy statement Feb 19, 2020 Mar 16, 2020
10-Q Quarterly report Feb 14, 2020 Dec 31, 2019
8-K Current report
Officer or director change
Feb 11, 2020 Feb 7, 2020
PRE 14A Preliminary proxy statement Feb 5, 2020 Mar 12, 2020
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 28, 2020 Jan 27, 2020
8-K Current report
Material agreement, Other events
Jan 27, 2020 Jan 21, 2020
424B1 Filing Jan 24, 2020 —
EFFECT Filing Jan 9, 2020 —
CORRESP Letter to the SEC Jan 9, 2020 —
CORRESP Letter to the SEC Jan 8, 2020 —
S-1/A Amended registration statement Jan 8, 2020 —
S-1/A Amended registration statement Jan 7, 2020 —
8-K/A Amended current report
Material agreement, Unregistered share sale
Jan 2, 2020 Dec 16, 2019
S-1/A Amended registration statement Dec 23, 2019 —
8-K Current report
Material agreement
Dec 19, 2019 Dec 16, 2019
FWP Free writing prospectus Dec 17, 2019 —
S-1/A Amended registration statement Dec 17, 2019 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Dec 13, 2019 Dec 13, 2019
UPLOAD Letter from the SEC Dec 9, 2019 —
S-1 Registration statement Nov 29, 2019 —
10-Q Quarterly report Nov 15, 2019 Sep 30, 2019
NT 10-Q Filing Nov 14, 2019 Sep 30, 2019
8-K Current report
Material agreement
Nov 6, 2019 Nov 1, 2019
RW Filing Nov 6, 2019 —
DEF 14A Proxy statement Oct 28, 2019 Dec 7, 2019
PRE 14A Preliminary proxy statement Oct 16, 2019 Oct 15, 2019
S-1 Registration statement Sep 27, 2019 —
8-K Current report
Bylaw or fiscal year change
Sep 26, 2019 Sep 22, 2019
10-K Annual report Aug 23, 2019 Jun 30, 2019
8-K Current report
Officer or director change
Aug 1, 2019 Jul 31, 2019
8-K Current report
Officer or director change
Jun 10, 2019 Jun 6, 2019
10-Q Quarterly report May 15, 2019 Mar 31, 2019
D Filing Mar 8, 2019 —
8-K Current report
Material agreement, Unregistered share sale
Mar 1, 2019 Feb 27, 2019
424B5 Prospectus supplement Mar 1, 2019 —
10-Q Quarterly report Feb 14, 2019 Dec 31, 2018
8-K Current report
Officer or director change
Feb 1, 2019 Feb 1, 2019
8-K Current report
Shareholder vote results
Dec 7, 2018 Nov 30, 2018
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
8-K Current report
Officer or director change
Oct 31, 2018 Oct 29, 2018
DEF 14A Proxy statement Oct 19, 2018 Nov 30, 2018
10-K Annual report Oct 12, 2018 Jun 30, 2018
NT 10-K Filing Sep 28, 2018 Jun 30, 2018
8-K/A Amended current report
Listing notice, Officer or director change
Sep 12, 2018 Sep 11, 2018
8-K Current report
Material agreement, Officer or director change
Jul 23, 2018 Jul 19, 2018
8-K Current report
Material agreement
Jul 19, 2018 Jul 11, 2018
8-K Current report
Listing notice, Officer or director change
Jul 11, 2018 Jul 3, 2018
10-Q Quarterly report May 21, 2018 Mar 31, 2018
NT 10-Q Filing May 15, 2018 Mar 31, 2018
8-K Current report
Material agreement, Unregistered share sale, Officer or director change
May 4, 2018 May 1, 2018
10-Q Quarterly report Feb 20, 2018 Dec 31, 2017
NT 10-Q Form 12b-25 Feb 14, 2018 Dec 31, 2017
8-K Current report
Shareholder vote results
Dec 15, 2017 Dec 8, 2017
424B5 Prospectus supplement Nov 22, 2017 —
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
DEFR14A Filing Nov 8, 2017 —
DEF 14A Proxy statement Oct 27, 2017 Dec 8, 2017
10-K Annual report Sep 28, 2017 Jun 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
EFFECT Filing Apr 25, 2017 —
CORRESP Letter to the SEC Apr 20, 2017 —
CORRESP Letter to the SEC Apr 18, 2017 —
S-3/A Filing Apr 18, 2017 —
UPLOAD Letter from the SEC Mar 15, 2017 —
S-3 Shelf registration Mar 1, 2017 —
10-Q Quarterly report Feb 14, 2017 Dec 31, 2016
8-K Current report
Material agreement, Unregistered share sale
Feb 13, 2017 Feb 8, 2017
8-K Current report
Shareholder vote results
Dec 15, 2016 Dec 11, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
DEF 14A Proxy statement Oct 28, 2016 Dec 11, 2016
10-K Annual report Sep 16, 2016 Jun 30, 2016
10-Q Quarterly report May 10, 2016 Mar 31, 2016
EFFECT Filing Apr 14, 2016 —
POS AM Filing Apr 7, 2016 —
10-Q Quarterly report Feb 9, 2016 Dec 31, 2015
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jan 29, 2016 Jan 23, 2016
DEF 14A Proxy statement Dec 8, 2015 Jan 23, 2016
10-Q Quarterly report Nov 9, 2015 Sep 30, 2015
10-K Annual report Sep 14, 2015 Jun 30, 2015

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NNVC (NYSE)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Shelton, CT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1379006

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.